Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals.

MLA

Rieger, C. T., et al. “Treatment Cost of Invasive Fungal Disease (Ifd) in Patients with Acute Myelogenous Leukaemia (Aml) or Myelodysplastic Syndrome (Mds) in German Hospitals.” Mycoses, vol. 55, no. 6, Nov. 2012, pp. 514–20. EBSCOhost, https://doi.org/10.1111/j.1439-0507.2012.02193.x.

APA

Rieger, C. T., Cornely, O. A., Hoppe-Tichy, T., Kiehl, M., Knoth, H., Thalheimer, M., Schuler, U., Ullmann, A. J., Ehlken, B., & Ostermann, H. (2012). Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals. Mycoses, 55(6), 514–520. https://doi.org/10.1111/j.1439-0507.2012.02193.x

Chicago

Rieger, C T, O A Cornely, T Hoppe-Tichy, M Kiehl, H Knoth, M Thalheimer, U Schuler, A J Ullmann, B Ehlken, and H Ostermann. 2012. “Treatment Cost of Invasive Fungal Disease (Ifd) in Patients with Acute Myelogenous Leukaemia (Aml) or Myelodysplastic Syndrome (Mds) in German Hospitals.” Mycoses 55 (6): 514–20. doi:10.1111/j.1439-0507.2012.02193.x.